These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 26472477)
61. Epidermal growth factor receptor-inhibition (EGFR-I) in the treatment of neuropathic pain. Kersten C; Cameron MG; Laird B; Mjåland S Br J Anaesth; 2015 Nov; 115(5):761-7. PubMed ID: 26475804 [TBL] [Abstract][Full Text] [Related]
62. Acupuncture for neuropathic pain: A meta-analysis of randomized control trials. Feng Z; Cui S; Yang H; Wang Y; Zhou X; Wong J; Lai L; Yang Z; Huang B; Zheng H; Xu M Front Neurol; 2022; 13():1076993. PubMed ID: 36698895 [TBL] [Abstract][Full Text] [Related]
63. Fractalkine/CX Silva R; Malcangio M Front Pain Res (Lausanne); 2021; 2():684684. PubMed ID: 35295489 [TBL] [Abstract][Full Text] [Related]
64. Function of Adenosine 2A Receptor in High-Fat Diet-Induced Peripheral Neuropathy. Li J; Liu HQ; Li XB; Yu WJ; Wang T J Diabetes Res; 2020; 2020():7856503. PubMed ID: 32566683 [TBL] [Abstract][Full Text] [Related]
65. Purinergic Signaling During Hyperglycemia in Vascular Smooth Muscle Cells. Martin-Aragon Baudel M; Espinosa-Tanguma R; Nieves-Cintron M; Navedo MF Front Endocrinol (Lausanne); 2020; 11():329. PubMed ID: 32528416 [TBL] [Abstract][Full Text] [Related]
66. Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. Effendi WI; Nagano T; Kobayashi K; Nishimura Y Cells; 2020 Mar; 9(3):. PubMed ID: 32213945 [TBL] [Abstract][Full Text] [Related]